reported that the proportion of CD8+ T cells with PD-1, Tim-3 and TIGHIT positivity in the BALF of patients with PD-1/PD-L1 inhibitor-induced ILD was significantly higher than that of patients with other types of ILD (74). This evidence concerns the gene HAVCR2 and interstitial lung disease.